AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3
Collins, T.
IDrugs the investigational drugs journal 10(12): 840-843
2007
ISSN/ISBN: 1369-7056 PMID: 18041675 Document Number: 608678
Document emailed within 1 workday
Related Documents
Garvey, R. 2006: AACR-NCI-EORTC--17th Symposium: Molecular Targets and Cancer Therapeutics IDrugs: the investigational drugs journal 9(2): 90-92Veryard, C. 2006: AACR-NCI-EORTC--17th symposium: Molecular targets and cancer therapeutics. 14-18th November 2005, Philadelphia, PA, USA IDrugs: the investigational drugs journal 9(1): 1-3
Lunec, A. 2004: EORTC-NCI-AACR--16th Symposium. Kinase inhibitors. 28 September-1 October 2004, Geneva, Switzerland IDrugs: the investigational drugs journal 7(11): 965-967
Kelland, L. 1998: NCI-EORTC--10th Symposium--new approaches and cellular targets. 16-19 June 1998, Amsterdam, The Netherlands IDrugs: the investigational drugs journal 1(4): 391-393
Scholl, S.M. 2001: Molecular targets and cancer therapeutics: discovery, biology and clinical applications Idrugs: the Investigational Drugs Journal 4(12): 1357-1360
Brissette, R.; Prendergast, J.K.A.; Goldstein, N.I. 2006: Identification of cancer targets and therapeutics using phage display Current Opinion in Drug Discovery and Development 9(3): 363-369
El-Deiry, W. 2000: AACR - 91st meeting. Novel concepts and targets for therapeutic manipulation IDrugs: the investigational drugs journal 3(7): 717-718
Herber, D.L. 2007: Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer IDrugs: the investigational drugs journal 10(4): 227-229
Mitsudomi, T. 2002: Molecular lesions as targets for diagnosis and therapy of lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(Suppl 1): 112-116
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Ashok, B.T.; Chen, Y.G.; Liu, X.; Garikapaty, V.P.S.; Seplowitz, R.; Tschorn, J.; Roy, K.; Mittelman, A.; Tiwari, R.K. 2002: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 11 Suppl. 2: S86-S93
Jakse, G. 1989: Intravesical instillation of BCG in carcinoma in situ of the urinary bladder. EORTC protocol 30861. EORTC-GU Group Progress in Clinical and Biological Research 310: 187-192
McKinnon, C. 1998: American Society of Clinical Oncology--34th Annual Meeting. Treatments for prostate cancer and new molecular targets. 16-19 May 1998, Los Angeles, California, USA IDrugs: the investigational drugs journal 1(2): 163-167
Cooper, T.W.; Gibbs, W.J.; Bronze, M.S.; Greenfield, R.A. 2006: Antimicrobial symposium. Part IV. Cephalosporins Journal of the Oklahoma State Medical Association 99(12): 579-583
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Woods, D. 1975: Community health symposium. Part I: a new togetherness and Indian care CanadianMedicalAssociationJournal 113(11-12): 1095
Renson, C.E.; Stanway, A.T. 1973: Therapeutics in dentistry. Analgesics: Part 2 Dental Update 1(4): 205-206
Rumore, M.M.; Rumore, J.S. 1989: Clinical therapeutics of endometriosis, Part 1 American Pharmacy 29(9): 49-54
Saklatvala, J.; Nagase, H. 2004: Report on the Molecular Approaches to Osteoarthritis Symposium, Imperial College London, UK, 18-20 April 2004 Arthritis Research and Therapy 6(5): 203-207
Robinson, M.R.; Smith, P.H.; Macaluso, M.P.; Sylvester, R.; de Voogt, H. 1985: The EORTC Phase IIi trials in prostatic cancer Progress in Clinical and Biological Research 185a: 243-249